DR. STUART CHARLES APFEL, MD
Neurology at Walker Pl, Hempstead, NY
License number
New York 168105-1
Category
Neurology
Type
Neurology
Address
Address
218 Walker Pl, Hempstead, NY 11552
Phone
(516) 505-0935
Personal information
See more information about STUART CHARLES APFEL at radaris.comName
Address
Phone
218 Walker Pl, West Hempstead, NY 11552
Hempstead, NY
218 Walker Pl, West Hempstead, NY 11552
Professional information
See more information about STUART CHARLES APFEL at trustoria.com
Dr. Stuart C Apfel, West Hempstead NY - MD (Doctor of Medicine)
Dr. Stuart C Apfel, West Hempstead NY - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology)
Address:
218 Walker Pl, West Hempstead 11552
(516) 505-0935 (Phone)
(516) 505-0935 (Phone)
Certifications:
Neurology, 1990
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Albert Einstein College of Medicine of Yeshiva University
Graduated: 1985
Brookdale University Hospital Medical Center
Albert Einstein Coll Med
Albert Einstein College of Medicine of Yeshiva University
Graduated: 1985
Brookdale University Hospital Medical Center
Albert Einstein Coll Med
Prevention And Treatment Of Peripheral Neuropathy
Prevention And Treatment Of Peripheral Neuropathy
US Patent:
5420112, May 30, 1995
Filed:
Apr 16, 1993
Appl. No.:
8/051191
Inventors:
Michael E. Lewis - West Chester PA
Stuart C. Apfel - West Hempstead NY
John A. Kessler - New Canaan CT
Stuart C. Apfel - West Hempstead NY
John A. Kessler - New Canaan CT
International Classification:
A61K 3800, A61K 3804, A61K 3808, A61K 3822
US Classification:
514 12
Abstract:
The invention features a method of preventing or treating a peripheral neuropathy that results from a systemic disease (e. g. , post-polio syndrome) or a toxic agent (e. g. , a chemotherapeutic agent), and that is not caused by an abnormal insulin level in a mammal. The method involves administering a neuropathy-reducing amount of insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to the mammal.
Use Of Ngf Growth Factors To Treat Drug-Induced Neuropathy
Use Of Ngf Growth Factors To Treat Drug-Induced Neuropathy
US Patent:
5604202, Feb 18, 1997
Filed:
Nov 17, 1993
Appl. No.:
8/153796
Inventors:
John A. Kessler - New Canaan CT
Stuart C. Apfel - West Hempstead NY
Stuart C. Apfel - West Hempstead NY
Assignee:
Albert Einstein College of Medicine of Yeshiva University, a Division of
Yeshiva University
Yeshiva University
International Classification:
A61K 3800, A61K 5100
US Classification:
514 12
Abstract:
This invention relates to the use of neuronotrophic factors, such as nerve growth factor (NGF), ciliary derived neuronotrophic factor (CNTF), brain derived neuronotrophic factor (BDNF), neuronotrophin-3 (NT-3), fibroblast growth factor (FGF), epidermal growth factor (EGF), transforming growth factor. varies. (TFG-. varies. ), transforming growth factor. beta. (TGF-. beta. ) and others to prevent drug-induced neuropathy.
Use Of Growth Factors To Treat Drug-Inducted Neuropathy
Use Of Growth Factors To Treat Drug-Inducted Neuropathy
US Patent:
6011004, Jan 4, 2000
Filed:
Dec 17, 1996
Appl. No.:
8/768221
Inventors:
John A. Kessler - New Canaan CT
Stuart C. Apfel - West Hempstead NY
Stuart C. Apfel - West Hempstead NY
Assignee:
Albert Einstein College of Medicine of Yeshiva University - Bronx NY
International Classification:
A61K 3818
US Classification:
514 2
Abstract:
This invention relates to the use of neuronotrophic factors, such as nerve growth factor (NGF), ciliary derived neuronotrophic factor (CNTF), brain derived neuronotrophic factor (BDNF), neuronotrophin-3 (NT-3), fibroblast growth factor (FGF), epidermal growth factor (EGF), transforming growth factor. alpha. (TFG-. alpha. ), transforming growth factor. beta. (TGF-. beta. ) and others to prevent drug-induced neuropathy.
Use Of Excitatory Opioid Receptor Antagonists To Prevent Growth Factor-Induced Hyperalgesia
Use Of Excitatory Opioid Receptor Antagonists To Prevent Growth Factor-Induced Hyperalgesia
US Patent:
5585348, Dec 17, 1996
Filed:
Aug 13, 1993
Appl. No.:
8/106401
Inventors:
Stanley M. Crain - Leonia NJ
Ke-fei Shen - Flushing NY
John A. Kessler - New Canaan CT
Stuart C. Apfel - West Hempstead NY
Ke-fei Shen - Flushing NY
John A. Kessler - New Canaan CT
Stuart C. Apfel - West Hempstead NY
Assignee:
Albert Einstein College of Medicine of Yeshiva University, a Division of
Yeshiva University - Bronx NY
Yeshiva University - Bronx NY
International Classification:
A61K 3800
US Classification:
514 12
Abstract:
This invention relates to a method of preventing hyperalgesia and other undesirable side-effects associated with the administration of growth factor, including nerve growth factor, utilizing an antagonist capable of inactivating excitatory opioid receptor-mediated functions on neurons in the nociceptive pathway. In addition, this invention relates to a composition comprising a growth factor and an antagonist capable of inactivating excitatory opioid receptor-mediated functions on neurons in the nociceptive pathway.
Prevention And Treatment Of Peripheral Neuropathy
Prevention And Treatment Of Peripheral Neuropathy
US Patent:
5648335, Jul 15, 1997
Filed:
Jun 4, 1996
Appl. No.:
8/658198
Inventors:
Michael E. Lewis - West Chester PA
Stuart C. Apfel - West Hempstead NY
John A. Kessler - New Canaan CT
Stuart C. Apfel - West Hempstead NY
John A. Kessler - New Canaan CT
Assignee:
Cephalon, Inc. - West Chester PA
Albert Einstein College of Medicine of Yeshiva Univ. - Bronx NY
Albert Einstein College of Medicine of Yeshiva Univ. - Bronx NY
International Classification:
A61K 3800, A61K 3804, A61K 3808, A61K 3802
US Classification:
514 12
Abstract:
The invention features a method of using insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to prevent or treat peripheral neuropathy in a mammal.
Prevention And Treatment Of Peripheral Neuropathy
Prevention And Treatment Of Peripheral Neuropathy
US Patent:
5569648, Oct 29, 1996
Filed:
Dec 29, 1994
Appl. No.:
8/365796
Inventors:
Michael E. Lewis - West Chester PA
Stuart C. Apfel - West Hempstead NY
John A. Kessler - New Canaan CT
Stuart C. Apfel - West Hempstead NY
John A. Kessler - New Canaan CT
Assignee:
Cephalon, Inc. - West Chester PA
Albert Einstein College of Medicine of Yeshiva University - Bronx NY
Albert Einstein College of Medicine of Yeshiva University - Bronx NY
International Classification:
A61K 3800, A61K 3804, A61K 3808, A61K 3822
US Classification:
514 12
Abstract:
The invention features a method of using insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to prevent or treat peripheral neuropathy in a mammal.
Prevention And Treatment Of Peripheral Neuropathy
Prevention And Treatment Of Peripheral Neuropathy
US Patent:
5633228, May 27, 1997
Filed:
Dec 29, 1994
Appl. No.:
8/366049
Inventors:
Michael E. Lewis - West Chester PA
Stuart C. Apfel - West Hempstead NY
John A. Kessler - New Canaan CT
Stuart C. Apfel - West Hempstead NY
John A. Kessler - New Canaan CT
Assignee:
Cephalon, Inc., - West Chester PA
Albert Einstein College of Medicine of Yeshiva University - Bronx NY
Albert Einstein College of Medicine of Yeshiva University - Bronx NY
International Classification:
A61K 3800, A61K 3827
US Classification:
514 12
Abstract:
The invention features a method of using insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to prevent or treat peripheral neuropathy in a mammal.